Numerous studies have implicated dysregulated CIA‐II expression in the malignant progression of multiple cancers, including cervical, lung, liver, and pancreatic cancers.6, 7, 8, 9. This evidence concerns the gene ASF1B and familial pancreatic carcinoma.